Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?

Core Insights - Thermo Fisher Scientific Inc. (TMO) is currently in the 18th and final phase of the Adhishthana Cycle across both weekly and monthly timeframes, indicating a transitional moment for the stock [3][12] - The stock has experienced a decline of 38% since entering the 18th phase, primarily due to bearish sentiment reflected in the weekly chart [6][10] - The monthly chart presents a contrasting narrative, suggesting potential for long-term upside, but the current weakness is driven by the bearish signals on the weekly chart [10][11] Weekly Chart Analysis - The Guna Triads for TMO in phases 14-16 were dominated by Rajoguna and Tamoguna, indicating indecision, volatility, and bearish sentiment [6][5] - The bearish 18th phase on the weekly chart is expected to continue until November 30, 2025, keeping the stock under pressure [10][11] - The 'Death Move' pattern suggests a significant correction after entering Phase 18 before potentially reaching Nirvana [10] Monthly Chart Analysis - The Guna Triads for the monthly chart in phases 14-16 were characterized by Satoguna, indicating a more constructive outlook [10] - The bullish signals on the monthly chart are anticipated to take precedence only after the conclusion of the bearish weekly phase in late 2025 [11] - The monthly Phase 18 does not conclude until July 31, 2030, suggesting long-term upside potential remains viable [12] Investment Strategy - Clients pursuing shorter timeframes have been implementing bearish spreads since the initiation of the weekly 18th phase [11] - A shift towards increased bullish exposure is expected post-2025 as the long-term value and Nirvana setup on the monthly chart becomes dominant [11] - TMO is positioned as a compelling candidate for patient investors looking to capitalize on deep-cycle insights, provided they time their investments appropriately [12]